![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, June 22, 2024 1:18:08 AM
-its a small Canadian company, tough to find 'love' on wall street, especially if its share price is 'cheap'
-given how much they have 'said' with respect to what they 'believe', I am leaning towards this 'can' help folks.
-I am tempted to buy shares for the PH 1/2 trial release that is 'anticipated' in Q3, but
-also wondering that IF this shows promise, and IF this doesn't show any side effects,
-will the FDA make them do a long drawn out PH 3 or
-will they allow for 'usage' as a PH 3 validation..
This has a lot of potential to help folks, again, they are chattering.. Yet no big pharma has bought them out. Is that an indication
that they have set a very high buyout price or big pharma isn't 'seeing' it yet..
Disclaimer: don't own any... But going to get some for the Q3 readout anticipated, just unsure as to how many shares, or what to expect on the news??
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM